Untargeted metabolomics and phenotype data indicate the therapeutic and prophylactic potential of <i>Lysimachia candida</i> Lindl. towards high-fat high-fructose-induced metabolic syndrome in rats

Alam, Jahangir; Kamboj, Parul; Sarkar, Soumalya; Gupta, Sonu Kumar; Kasarla, Siva Swapna; Bajpai, Sneha; Kumari, Deepika; Bisht, N. S.; Barge, Sagar; Kashyap, Bhaswati; Deka, Barsha; Bharadwaj, Simanta; Rahman, Seydur; Dutta, Partha; Borah, Jagat C.; Talukdar, Narayan Chandra; Kumar, Yashwant; Banerjee, Sanjay K.

doi:10.1039/d3mo00104k

Mol. Omics

2023

DOI: 10.1039/d3mo00104k

|View full text |Cite

Untargeted metabolomics and phenotype data indicate the therapeutic and prophylactic potential of Lysimachia candida Lindl. towards high-fat high-fructose-induced metabolic syndrome in rats

Jahangir Alam¹,

Parul Kamboj²,

Soumalya Sarkar³

et al.

Abstract: The present study evaluated the therapeutic potential of the medicinal plant Lysimachia candida Lindl. against metabolic syndrome in male SD rats fed with a high-fat high-fructose (HFHF) diet. Methanolic extract...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions

Olalekan,

Bakare,

Osonuga

et al. 2024

Egypt J Intern Med

View full text Add to dashboard Cite

Background The gut microbiota (GM) and their metabolites have garnered significant attention for their roles in metabolic syndrome (MetS) and associated conditions. MetS, characterized by a cluster of metabolic abnormalities, significantly increases the risk of cardiovascular disease (CVD), obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). The dysbiosis of gut microbiota, marked by changes in microbial composition and function, has been implicated in the pathogenesis of MetS. Main body This review synthesizes recent findings elucidating the influence of GM composition and microbiota-derived metabolites on MetS pathogenesis and progression. Notably, alterations in GM composition and dysregulation of metabolites such as short-chain fatty acids (SCFAs), trimethylamine N-oxide (TMAO), polyamines, amino acids, and indole derivatives have been implicated in MetS development. These metabolites play crucial roles in metabolic processes, and their imbalance can trigger or exacerbate metabolic disturbances associated with MetS. Various therapeutic approaches, including dietary interventions, probiotics, prebiotics, and precision medicine targeting specific metabolites, offer promising strategies for managing MetS. These interventions aim to restore a healthy GM balance and regulate the production of beneficial metabolites. Conclusion The complexity of GM interactions and their systemic effects necessitate more standardized research methodologies. Future investigations focusing on personalized therapeutic interventions and non-invasive diagnostic tools are warranted to address the complexities of MetS management. Advancing our understanding of the GM-metabolite-MetS axis will be crucial for developing effective, targeted treatments and improving patient outcomes in MetS.

show abstract

Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions

Olalekan,

Bakare,

Osonuga

et al. 2024

Egypt J Intern Med

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Untargeted metabolomics and phenotype data indicate the therapeutic and prophylactic potential of Lysimachia candida Lindl. towards high-fat high-fructose-induced metabolic syndrome in rats

Abstract: The present study evaluated the therapeutic potential of the medicinal plant Lysimachia candida Lindl. against metabolic syndrome in male SD rats fed with a high-fat high-fructose (HFHF) diet. Methanolic extract...

Cited by 1 publication

References 46 publications

Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions

Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions

Contact Info

Product

Resources

About